{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:02:49Z","timestamp":1789459369924,"version":"build-2803163510"},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"18","funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372996"],"award-info":[{"award-number":["82372996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"the Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2022NSCQ-MSX1277"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1277"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"the Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2023NSCQ-MSX0480"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0480"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Technologies R&D Program","award":["2022YFA1303600"],"award-info":[{"award-number":["2022YFA1303600"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U23A20472"],"award-info":[{"award-number":["U23A20472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273423"],"award-info":[{"award-number":["82273423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The clinical efficacy of lenvatinib, a multitarget tyrosine kinase inhibitor used as a first-line treatment for advanced hepatocellular carcinoma (HCC), is frequently compromised by the development of drug resistance. Elucidating the molecular mechanisms underlying this resistance is essential to improving therapeutic outcomes. Using patient-derived organoids (PDO) and orthotopic HCC xenograft models, we uncovered a role for epidermal growth factor receptor (EGFR) in lenvatinib resistance. Most PDOs recapitulated the limited clinical response to lenvatinib and displayed significant resistance. Notably, resistant organoids exhibited enhanced N-glycosylation of EGFR, which correlated with increased EGFR protein expression. Functional studies demonstrated that inhibiting either global N-glycosylation or EGFR signaling restored lenvatinib sensitivity in cellular and in vivo models. Integrated proteomic and N-glycoproteomic analyses identified bifunctional heparan sulfate N-deacetylase\/N-sulfotransferase 2 (NDST2) as the key enzyme mediating site-specific N-glycosylation of EGFR at four conserved asparagine residues (N175, N196, N413, and N623). NDST2-catalyzed glycosylation enhanced EGFR stability by suppressing ubiquitin\u2013proteasomal degradation and promoted its membrane localization, thereby activating multiple prosurvival pathways, including MAPK, PI3K\/AKT, and JAK\/STAT. Clinically, NDST2 was upregulated in lenvatinib-resistant HCC specimens and positively correlated with EGFR expression. Importantly, targeting NDST2 via genetic ablation or inhibition using a CaCO3 nanoparticle\u2013based small interfering RNA delivery system effectively reversed lenvatinib resistance in HCC tumor models. These findings establish NDST2-driven EGFR N-glycosylation as a critical mechanism of lenvatinib resistance in HCC and highlight NDST2 as a promising therapeutic target for restoring drug sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>NDST2 catalyzes glycosylation that stabilizes EGFR and enhances downstream oncogenic signaling in hepatocellular carcinoma to confer resistance to lenvatinib, which can be overcome by targeting the NDST2-EGFR axis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-25-4582","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:19:13Z","timestamp":1782148753000},"page":"4569-4588","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9267-4805","authenticated-orcid":false,"given":"Huiying","family":"Gu","sequence":"first","affiliation":[{"name":"1Department of Infectious Disease, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China."},{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."},{"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chongqing Medical University 3 College of Laboratory Medicine, , Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-7084","authenticated-orcid":false,"given":"Fan","family":"Li","sequence":"additional","affiliation":[{"name":"4Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1567-1702","authenticated-orcid":false,"given":"Yuyan","family":"Chen","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4954-0654","authenticated-orcid":false,"given":"Mengling","family":"Zhang","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2786-2593","authenticated-orcid":false,"given":"Qiumin","family":"Wu","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6579-8131","authenticated-orcid":false,"given":"Haibei","family":"Zhao","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7611-837X","authenticated-orcid":false,"given":"Chongyang","family":"Zhou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chongqing Medical University 3 College of Laboratory Medicine, , Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5817-0143","authenticated-orcid":false,"given":"Li","family":"Yan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chongqing Medical University 5 College of Medical Informatics, , Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2377-2332","authenticated-orcid":false,"given":"Ruixi","family":"Xie","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chongqing Medical University 3 College of Laboratory Medicine, , Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1880-6541","authenticated-orcid":false,"given":"Xinchang","family":"Huang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chongqing Medical University 6 State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, , Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3481-2223","authenticated-orcid":false,"given":"Jihua","family":"Ren","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4216-218X","authenticated-orcid":false,"given":"Shengtao","family":"Cheng","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6221-2416","authenticated-orcid":false,"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6294-3535","authenticated-orcid":false,"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"7Department of Hepatobillary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-3628","authenticated-orcid":false,"given":"Zhenzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Infectious Disease, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6920-7972","authenticated-orcid":false,"given":"Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Infectious Disease, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China."},{"name":"2Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."},{"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chongqing Medical University 3 College of Laboratory Medicine, , Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026091503083999000_bib1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026091503083999000_bib2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026091503083999000_bib3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"2026091503083999000_bib4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40265-019-01116-x","article-title":"Lenvatinib: a review in hepatocellular carcinoma","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs"},{"key":"2026091503083999000_bib5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1053\/j.gastro.2011.03.006","article-title":"Targeted therapies for hepatocellular carcinoma","volume":"140","author":"Villanueva","year":"2011","journal-title":"Gastroenterology"},{"key":"2026091503083999000_bib6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy","volume":"44","author":"Qin","year":"2024","journal-title":"Liver Int"},{"key":"2026091503083999000_bib7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/hep.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2023","journal-title":"Hepatology"},{"key":"2026091503083999000_bib8","doi-asserted-by":"publisher","first-page":"104069","DOI":"10.1016\/j.drudis.2024.104069","article-title":"New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma","volume":"29","author":"Fan","year":"2024","journal-title":"Drug Discov Today"},{"key":"2026091503083999000_bib9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.tips.2019.10.004","article-title":"A third shot at EGFR: new opportunities in cancer therapy","volume":"40","author":"Guardiola","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"2026091503083999000_bib10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.canlet.2019.10.030","article-title":"EGFR-mediated autophagy in tumourigenesis and therapeutic resistance","volume":"469","author":"Wu","year":"2020","journal-title":"Cancer Lett"},{"key":"2026091503083999000_bib11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tem.2009.06.008","article-title":"The EGFR network in bone biology and pathology","volume":"20","author":"Schneider","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"2026091503083999000_bib12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1053\/j.gastro.2023.01.023","article-title":"EGFR\/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma","volume":"164","author":"Lim","year":"2023","journal-title":"Gastroenterology"},{"key":"2026091503083999000_bib13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"key":"2026091503083999000_bib14","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3\u2013ABCB1 signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res"},{"key":"2026091503083999000_bib15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2023.03.003","article-title":"Multiple post-translational modifications ensure EGFR functionality: potential therapeutic targets to overcome its drug-resistance mutations","volume":"70","author":"He","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026091503083999000_bib16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2023.10.014","article-title":"The role of N-glycosylation in cancer","volume":"14","author":"Lin","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"2026091503083999000_bib17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2026091503083999000_bib18","doi-asserted-by":"publisher","first-page":"189274","DOI":"10.1016\/j.bbcan.2025.189274","article-title":"Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies","volume":"1880","author":"Granica","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026091503083999000_bib19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","article-title":"Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"2026091503083999000_bib20","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1073\/pnas.1503262112","article-title":"N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes","volume":"112","author":"Kaszuba","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026091503083999000_bib21","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/prot.25314","article-title":"Role of N-glycosylation in EGFR ectodomain ligand binding","volume":"85","author":"Irani","year":"2017","journal-title":"Proteins"},{"key":"2026091503083999000_bib22","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.1074\/jbc.RA119.008643","article-title":"N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2)","volume":"294","author":"Chandler","year":"2019","journal-title":"J Biol Chem"},{"key":"2026091503083999000_bib23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"2026091503083999000_bib24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"2026091503083999000_bib25","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1074\/jbc.274.4.1966","article-title":"Functional analysis of conserved cysteines in heparan sulfate N-deacetylase-N-sulfotransferases","volume":"274","author":"Wei","year":"1999","journal-title":"J Biol Chem"},{"key":"2026091503083999000_bib26","doi-asserted-by":"publisher","first-page":"e002699","DOI":"10.1136\/jitc-2021-002699","article-title":"PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy","volume":"9","author":"Xu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026091503083999000_bib27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026091503083999000_bib28","doi-asserted-by":"publisher","first-page":"11332","DOI":"10.1073\/pnas.1107385108","article-title":"Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026091503083999000_bib29","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1074\/jbc.M510893200","article-title":"Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"2026091503083999000_bib30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13048-018-0385-0","article-title":"Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death","volume":"11","author":"Britain","year":"2018","journal-title":"J Ovarian Res"},{"key":"2026091503083999000_bib31","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/glycob\/cwm048","article-title":"Metabolic homeostasis and tissue renewal are dependent on \u03b21,6GlcNAc-branched N-glycans","volume":"17","author":"Cheung","year":"2007","journal-title":"Glycobiology"},{"key":"2026091503083999000_bib32","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1021\/bi027101p","article-title":"Characterization of glycosylation sites of the epidermal growth factor receptor","volume":"42","author":"Zhen","year":"2003","journal-title":"Biochemistry"},{"key":"2026091503083999000_bib33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/oxfordjournals.jbchem.a022585","article-title":"Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor","volume":"127","author":"Sato","year":"2000","journal-title":"J Biochem"},{"key":"2026091503083999000_bib34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/08977199609034572","article-title":"Analysis of the glycosylation patterns of the extracellular domain of the epidermal growth factor receptor expressed in Chinese hamster ovary fibroblasts","volume":"13","author":"Smith","year":"1996","journal-title":"Growth Factors"},{"key":"2026091503083999000_bib35","doi-asserted-by":"publisher","first-page":"18600","DOI":"10.1074\/jbc.M116.744433","article-title":"NDST2 (N-Deacetylase\/N-Sulfotransferase-2) enzyme regulates heparan sulfate chain length","volume":"291","author":"Deligny","year":"2016","journal-title":"J Biol Chem"},{"key":"2026091503083999000_bib36","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1074\/jbc.m009606200","article-title":"Multiple isozymes of heparan sulfate\/heparin GlcNAcN-deacetylase\/GlcN N-sulfotransferase","volume":"276","author":"Aikawa","year":"2001","journal-title":"J Biol Chem"},{"key":"2026091503083999000_bib37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1369\/jhc.2010.955161","article-title":"Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer","volume":"58","author":"T\u00e1trai","year":"2010","journal-title":"J Histochem Cytochem"},{"key":"2026091503083999000_bib38","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1080\/21655979.2021.1987820","article-title":"Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"key":"2026091503083999000_bib39","doi-asserted-by":"publisher","first-page":"e0150132","DOI":"10.1371\/journal.pone.0150132","article-title":"Syndecan-1-induced ECM fiber alignment requires integrin \u03b1v\u03b23 and syndecan-1 ectodomain and heparan sulfate chains","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4582\/3805136\/can-25-4582.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4582\/3813358\/can-25-4582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/18\/4569\/3829587\/can-25-4582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/18\/4569\/3829587\/can-25-4582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:08:54Z","timestamp":1789456134000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/18\/4569\/787809\/EGFR-N-Glycosylation-Catalyzed-by-NDST2-Promotes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":39,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,6,22]]},"published-print":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-4582","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.33776333","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776300","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776324","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776315","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776348","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776318","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776339","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776306","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776330","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776297","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776342","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776291","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.33776309","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8715362","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}